Why 3/5: Enhances an existing public health program by adding educational requirements for providers, improving patient care.
The state's sickle cell screening and treatment program will expand its operational scope by requiring the offering of educational resources to healthcare providers. These resources will inform providers about the increased risks for certain cancers among individuals with sickle cell disease or the sickle cell trait.
Cleared committee
Reported from Education and Health (15-Y 0-N)
Update
Rules suspended
Update
Constitutional reading dispensed Block Vote (on 2nd reading) (37-Y 0-N 0-A)
Update
Passed by for the day Block Vote (Voice Vote)
Third reading
Read third time
Passed a chamber
Passed Senate (40-Y 0-N 0-A)
Enrolled
Enrolled
Passed a chamber
Bill text as passed House and Senate (HB392ER)
Update
Fiscal Impact Statement from Department of Planning and Budget (HB392)
This bill has passed its votes and is headed to the Governor's desk. You still have a say — the Governor's office reads messages before deciding whether to sign.
New to all this? See how a bill becomes law →
Summarized from the official bill text (“Sickle cell disease education and screening program; cancer risk.”) · Read the actual bill →
Passed a chamber
Signed by Speaker
Passed a chamber
Signed by President
Enrolled
Enrolled Bill communicated to Governor on March 10, 2026
Sent to the Governor
Governor's Action Deadline 11:59 p.m., April 13, 2026
Signed into law
Approved by Governor-Chapter 600 (effective 7/1/2026)
Update
Acts of Assembly Chapter text (CHAP0600)